2015
DOI: 10.1016/j.jep.2014.12.034
|View full text |Cite
|
Sign up to set email alerts
|

In vitro evaluation of dual agonists for PPARγ/β from the flower of Edgeworthia gardneri (wall.) Meisn

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
22
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 35 publications
0
22
0
Order By: Relevance
“…Recently, researches have been focused on finding anti-obesity agents from natural products as that they have slight or no side effects. The flower of E.gardneri is widely used as Tibetan folk medicine for the treatment of metabolic diseases (Gao et al, 2015a). But the anti-obesity effect of the flower of E.gardneri has not been investigated.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, researches have been focused on finding anti-obesity agents from natural products as that they have slight or no side effects. The flower of E.gardneri is widely used as Tibetan folk medicine for the treatment of metabolic diseases (Gao et al, 2015a). But the anti-obesity effect of the flower of E.gardneri has not been investigated.…”
Section: Discussionmentioning
confidence: 99%
“…Though, the extracts reduced in the diabetes-induced renal damage related to the diabetic nephropathy [10]. Moreover, the extracts improved the effects of non-enzymatic and enzymatic antioxidants [11], also in vitro augmented the glycolytic activities [12]. These results propose a rationale for more studies utilizing combinations of the extracts and PDE-5 inhibitors in diabetes-induced ED.…”
Section: Discussionmentioning
confidence: 78%
“…12 Moreover, the treatment improved the activities of enzymatic and nonenzymatic antioxidants, 13 and also in vitro increased the glycolytic activities. 14 These results indicate a rationale for more studies using combinations of extracts and phosphodiesterase-5 inhibitors in diabetes-induced ED.…”
Section: Discussionmentioning
confidence: 89%